| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $120K | +25.0% |
| SG&A Expense | $1.9M | -42.4% |
| Operating Income | -$2.0M | +40.4% |
| Net Income | -$2.6M | +41.4% |
| EPS (Basic) | $0.00 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $77K | -71.5% |
| Short-term Investments | $15K | +0.0% |
| Current Assets | $185K | -47.0% |
| Total Assets | $1.3M | +24.1% |
| Current Liabilities | $1.8M | +69.6% |
| Total Liabilities | $3.8M | +51.5% |
| Stockholders' Equity | -$2.5M | -71.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$567K | +2.6% |
| Capital Expenditures | $4K | -98.4% |
| Investing Cash Flow | $11K | -96.2% |
| Financing Cash Flow | $360K | +2.9% |
| Free Cash Flow | -$571K | +31.5% |